Peripheral blood Th9 cells as a possible pharmacodynamics biomarker of nivolumab treatment efficacy in metastatic melanoma
0301 basic medicine
03 medical and health sciences
DOI:
10.1016/j.jdermsci.2017.02.240
Publication Date:
2017-04-08T10:05:45Z
AUTHORS (5)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....